EA201101349A1 - Методы лечения отека, связанного с ишемией-реперфузией - Google Patents

Методы лечения отека, связанного с ишемией-реперфузией

Info

Publication number
EA201101349A1
EA201101349A1 EA201101349A EA201101349A EA201101349A1 EA 201101349 A1 EA201101349 A1 EA 201101349A1 EA 201101349 A EA201101349 A EA 201101349A EA 201101349 A EA201101349 A EA 201101349A EA 201101349 A1 EA201101349 A1 EA 201101349A1
Authority
EA
Eurasian Patent Office
Prior art keywords
reperfusion
ischemia
treatment methods
domestic associated
domestic
Prior art date
Application number
EA201101349A
Other languages
English (en)
Russian (ru)
Inventor
Томас Майкл Эган
Original Assignee
Университет Северной Каролины В Чапел-Хилл
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Университет Северной Каролины В Чапел-Хилл filed Critical Университет Северной Каролины В Чапел-Хилл
Publication of EA201101349A1 publication Critical patent/EA201101349A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/12Chemical aspects of preservation
    • A01N1/122Preservation or perfusion media
    • A01N1/126Physiologically active agents, e.g. antioxidants or nutrients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
EA201101349A 2009-04-09 2010-04-09 Методы лечения отека, связанного с ишемией-реперфузией EA201101349A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16808909P 2009-04-09 2009-04-09
PCT/US2010/030556 WO2010118334A1 (en) 2009-04-09 2010-04-09 Methods of treating edema related to ischemia-reperfusion

Publications (1)

Publication Number Publication Date
EA201101349A1 true EA201101349A1 (ru) 2012-05-30

Family

ID=42936599

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201101349A EA201101349A1 (ru) 2009-04-09 2010-04-09 Методы лечения отека, связанного с ишемией-реперфузией

Country Status (14)

Country Link
US (1) US20120064044A1 (https=)
EP (1) EP2416651A4 (https=)
JP (1) JP2012523432A (https=)
KR (1) KR20120005025A (https=)
CN (1) CN102458113A (https=)
AU (1) AU2010233151A1 (https=)
BR (1) BRPI1010516A2 (https=)
CA (1) CA2757998A1 (https=)
EA (1) EA201101349A1 (https=)
IL (1) IL215604A0 (https=)
MX (1) MX2011010616A (https=)
SG (1) SG175133A1 (https=)
WO (1) WO2010118334A1 (https=)
ZA (1) ZA201107815B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0911195A2 (pt) * 2008-04-09 2017-06-20 The Univ Of North Caroline At Chapel Hill métodos de regulação de arranjo de citoesqueleto de actina e formação de gap intracelular
CN103492572A (zh) 2011-03-03 2014-01-01 夸克医药公司 用于治疗肺疾病和损伤的组合物和方法
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
CN110446511B (zh) 2017-03-10 2024-04-02 北卡罗来纳大学查珀尔希尔分校 短效的基于肝素的抗凝血剂化合物和方法
WO2019010216A1 (en) 2017-07-03 2019-01-10 The University Of North Carolina At Chapel Hill ENZYMATIC SYNTHESIS OF HOMOGENEOUS CHONDROITIN SULFATE OLIGOSACCHARIDES
JP7495061B2 (ja) 2017-11-03 2024-06-04 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 抗炎症作用を有する硫酸化オリゴ糖
ES2985591T3 (es) 2018-02-12 2024-11-06 Inimmune Corp Ligandos de receptores tipo Toll
CN112437667B (zh) 2018-06-20 2024-05-28 北卡罗来纳大学查珀尔希尔分校 细胞保护方法和组合物
WO2021097345A1 (en) * 2019-11-13 2021-05-20 The University Of North Carolina At Chapel Hill Heparan sulfate (hs) oligosaccharides effect in liver ischemia reperfusion injury

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05139992A (ja) * 1991-11-13 1993-06-08 Ajinomoto Co Inc ヒトadfを含有する臓器保護剤
US6113918A (en) * 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US7960522B2 (en) * 2003-01-06 2011-06-14 Corixa Corporation Certain aminoalkyl glucosaminide phosphate compounds and their use
JPWO2004085396A1 (ja) * 2003-03-26 2006-06-29 三菱ウェルファーマ株式会社 虚血再灌流障害の予防または治療剤、臓器保存剤およびスクリーニング方法
US20060211752A1 (en) * 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US7928132B2 (en) * 2004-08-06 2011-04-19 Ohio University Methods for the amelioration of episodes of acute or chronic ulcerative colitis
US8734788B2 (en) * 2007-08-03 2014-05-27 Opsona Therapeutics Ltd Composition and method for treatment of reperfusion injury and tissue damage
BRPI0911195A2 (pt) * 2008-04-09 2017-06-20 The Univ Of North Caroline At Chapel Hill métodos de regulação de arranjo de citoesqueleto de actina e formação de gap intracelular

Also Published As

Publication number Publication date
AU2010233151A1 (en) 2011-11-17
JP2012523432A (ja) 2012-10-04
EP2416651A1 (en) 2012-02-15
US20120064044A1 (en) 2012-03-15
MX2011010616A (es) 2012-03-14
SG175133A1 (en) 2011-12-29
WO2010118334A1 (en) 2010-10-14
KR20120005025A (ko) 2012-01-13
BRPI1010516A2 (pt) 2015-08-25
CN102458113A (zh) 2012-05-16
EP2416651A4 (en) 2014-03-26
ZA201107815B (en) 2013-04-24
IL215604A0 (en) 2011-12-29
CA2757998A1 (en) 2010-10-14

Similar Documents

Publication Publication Date Title
EA201101349A1 (ru) Методы лечения отека, связанного с ишемией-реперфузией
BRPI1013881A2 (pt) composição detergente, e, método doméstico de tratamento de tecido
EP2569434A4 (en) COMPOSITIONS AND METHODS OF TREATING LEUKEMIA
PH12013500449A1 (en) Treatment of diseases
CL2012002229A1 (es) Compuestos derivados de macrociclos inhibidores del factor de coagulacion xia; utiles en el tratmiento de enfermedades tromboembolicas.
EP2477985A4 (en) CANCER TREATMENT
EA201170521A1 (ru) Новые соединения
EA201290901A1 (ru) Фитоканнабиноиды для лечения злокачественной опухоли
EA201290988A1 (ru) Стереоселективный синтез фосфорсодержащих активных соединений
EA201171367A1 (ru) Винилиндазолильные соединения
BR112013032229A2 (pt) método de tratamento hidrocatalítico hidrotérmico de biomassa, e, composição
MX2011008221A (es) Tratamiento de cancer de pulmon con un compuesto de nitrobenzamida en combinacion con un inhibidor de un factor de crecimieno.
CR11870A (es) Composiciones de perácido y 2-hidroxi ácido orgánico y métodos para tratar productos agrícolas
CL2012003385A1 (es) Tratamiento para la incontinencia.
BR112012019302A2 (pt) imidazo[1,2-b][1,2,4]triazinas como inibidores de c-met
EA201100874A1 (ru) Соединения для лечения рака
EA201170294A1 (ru) Способы лечения реперфузионных повреждений
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species
BR112012003111A8 (pt) Métodos para tratar iontoforeticamente náusea e enxaqueca
EA201171155A1 (ru) 5-β ПРОИЗВОДНЫЕ 14-β-АНДРОСТАНА ДЛЯ ЛЕЧЕНИЯ ПРОТЕИНУРИИ, ГЛОМЕРУЛОСКЛЕРОЗА И ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ
MY156873A (en) Novel forms of a multicyclic compound
UA103197C2 (uk) Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами
MX2012000203A (es) Procedimientos de uso del factor liberador de corticotropina para el tratamiento de cancer.
IN2012DN01846A (https=)
UA80026U (ru) Способ выполнения панкреатодуоденальной резекции